OverT Bio Receives $120K G-Rex® Grant to Propel Solid Tumor Cell Therapy AdvancementsBusiness Wire • Friday
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCHPRNewsWire • Monday
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPOPRNewsWire • 11/14/24
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSPRNewsWire • 11/11/24
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene TherapyPRNewsWire • 11/07/24
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETINGPRNewsWire • 11/06/24
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCHPRNewsWire • 11/05/24
Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in PremarketZacks Investment Research • 10/30/24
Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares riseReuters • 10/30/24
BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTSPRNewsWire • 10/10/24
ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer InstitutePRNewsWire • 10/08/24
ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. KlebanoffPRNewsWire • 10/07/24
LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCHPRNewsWire • 09/26/24
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETINGPRNewsWire • 09/24/24